Table 1 Anti-CMV serological response amongst each group
From: Cytolytic T-cell response against Epstein-Barr virus in lung cancer patients and healthy subjects
Subject group | Mean ± Standard deviationa | Rangea | p |
|---|---|---|---|
Young healthy individuals | 267 ± 183 | 8-486 | Young vs Aged: 0.049 |
Aged healthy individuals | 377 ± 83 | 411-612 | Young vs Patients: 0.466 |
Patients with lung cancer | 341 ± 199 | 22-831 | Aged vs Patients: 0.024 |